These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


298 related items for PubMed ID: 19263753

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients.
    Scheenstra RJ, Rijntjes E, Tavy DL, Kingma H, Heijerman HG.
    Acta Otolaryngol; 2009 Jan; 129(1):4-7. PubMed ID: 18607923
    [Abstract] [Full Text] [Related]

  • 25. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M, Mouton JW, Schoemaker RC, Verduin CM, van den Anker JN.
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis.
    Clavel A, Boulaméry A, Bosdure E, Luc C, Lanteaume A, Gorincour G, Stremler-Lebel N, Sarles J, Andrieu V, Dubus JC.
    J Cyst Fibros; 2007 Apr; 6(2):137-43. PubMed ID: 16839826
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF, McElnay JC, Elborn JS, Tunney MM.
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of two blood sampling methods in anticoagulation therapy: venipuncture and peripheral venous catheter.
    Zengin N, Enç N.
    J Clin Nurs; 2008 Feb; 17(3):386-93. PubMed ID: 17394539
    [Abstract] [Full Text] [Related]

  • 35. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis.
    Bui S, Babre F, Hauchecorne S, Christoflour N, Ceccato F, Boisserie-Lacroix V, Clouzeau H, Fayon M.
    J Cyst Fibros; 2009 Sep; 8(5):326-31. PubMed ID: 19660993
    [Abstract] [Full Text] [Related]

  • 36. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?
    Soulsby N, Bell S, Greville H, Doecke C.
    Intern Med J; 2009 Aug; 39(8):527-31. PubMed ID: 19220547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Falsely elevated serum tobramycin concentrations in cystic fibrosis patients treated with concurrent intravenous and inhaled tobramycin.
    Elidemir O, Maciejewski SR, Oermann CM.
    Pediatr Pulmonol; 2000 Jan; 29(1):43-5. PubMed ID: 10613786
    [Abstract] [Full Text] [Related]

  • 40. Comparing the results of coagulation tests on blood drawn by venipuncture and through heparinized tunneled venous access devices in pediatric patients with cancer.
    Hinds PS, Quargnenti A, Gattuso J, Kumar Srivastova D, Tong X, Penn L, West N, Cathey P, Hawkins D, Wilimas J, Starr M, Head D.
    Oncol Nurs Forum; 2002 Apr; 29(3):E26-34. PubMed ID: 11979291
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.